Characterization of the Protective Efficacy Against QX Strain of a Recombinant Infectious Bronchitis Virus With H120 Backbone and QX Spike Gene

Infectious bronchitis virus (IBV) has been prevalent in chicken farms for many years, and its control relies on extensive vaccine administration. The continuous emergence of new variants and the low cross-protection efficiency prompt the development of new vaccines. In this study, we develop a rever...

Full description

Bibliographic Details
Main Authors: Wenlian Weng, Qingyan Liu, Wenxiang Xue, Huan Wang, Shouguo Fang, Yingjie Sun, Lei Tan, Cuiping Song, Xusheng Qiu, Weiwei Liu, Chan Ding, Ying Liao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2022.883642/full
_version_ 1818252462973255680
author Wenlian Weng
Qingyan Liu
Qingyan Liu
Wenxiang Xue
Huan Wang
Shouguo Fang
Yingjie Sun
Lei Tan
Cuiping Song
Xusheng Qiu
Weiwei Liu
Chan Ding
Chan Ding
Ying Liao
author_facet Wenlian Weng
Qingyan Liu
Qingyan Liu
Wenxiang Xue
Huan Wang
Shouguo Fang
Yingjie Sun
Lei Tan
Cuiping Song
Xusheng Qiu
Weiwei Liu
Chan Ding
Chan Ding
Ying Liao
author_sort Wenlian Weng
collection DOAJ
description Infectious bronchitis virus (IBV) has been prevalent in chicken farms for many years, and its control relies on extensive vaccine administration. The continuous emergence of new variants and the low cross-protection efficiency prompt the development of new vaccines. In this study, we develop a reverse genetics technique based on the classical vaccine strain H120 genome, via in vitro ligation method. Using the H120 genome as the backbone, we constructed the recombinant virus rH120-QX(S) by replacing the H120 S gene with the QX S gene, a prevalent strain in China. Biological characteristics of the rH120-QX(S) virus, such as 50% egg lethal dose (ELD50), 50% egg infectious dose (EID50), dwarf embryo, growth curve, and genetic stability, are measured, which are comparable to the parental virus H120. There are no clinical symptoms and tissue lesions in the trachea and kidney in the rH120-QX(S)-infected specific-pathogen-free (SPF) chickens, demonstrating that this recombinant virus does not confer pathogenicity. Furthermore, protection studies show that there is 100% homologous protection of rH120-QX(S) to the virulent QX strain, as shown by the absence of clinical signs and no lethality. Taken together, our results demonstrate that swapping the S gene onto the H120 genetic backbone is a precise and effective way to produce genetically defined IBV vaccine candidates.
first_indexed 2024-12-12T16:24:34Z
format Article
id doaj.art-cf71cac54b604ce985b52ddb49e71cad
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-12-12T16:24:34Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-cf71cac54b604ce985b52ddb49e71cad2022-12-22T00:18:55ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2022-06-011310.3389/fmicb.2022.883642883642Characterization of the Protective Efficacy Against QX Strain of a Recombinant Infectious Bronchitis Virus With H120 Backbone and QX Spike GeneWenlian Weng0Qingyan Liu1Qingyan Liu2Wenxiang Xue3Huan Wang4Shouguo Fang5Yingjie Sun6Lei Tan7Cuiping Song8Xusheng Qiu9Weiwei Liu10Chan Ding11Chan Ding12Ying Liao13Department of Avian Diseases, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, ChinaDepartment of Avian Diseases, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, ChinaCollege of Agriculture, College of Animal Sciences, Yangtze University, Jingzhou, ChinaDepartment of Avian Diseases, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, ChinaDepartment of Avian Diseases, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, ChinaCollege of Agriculture, College of Animal Sciences, Yangtze University, Jingzhou, ChinaDepartment of Avian Diseases, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, ChinaDepartment of Avian Diseases, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, ChinaDepartment of Avian Diseases, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, ChinaDepartment of Avian Diseases, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, ChinaDepartment of Avian Diseases, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, ChinaDepartment of Avian Diseases, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, ChinaJiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, ChinaDepartment of Avian Diseases, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, ChinaInfectious bronchitis virus (IBV) has been prevalent in chicken farms for many years, and its control relies on extensive vaccine administration. The continuous emergence of new variants and the low cross-protection efficiency prompt the development of new vaccines. In this study, we develop a reverse genetics technique based on the classical vaccine strain H120 genome, via in vitro ligation method. Using the H120 genome as the backbone, we constructed the recombinant virus rH120-QX(S) by replacing the H120 S gene with the QX S gene, a prevalent strain in China. Biological characteristics of the rH120-QX(S) virus, such as 50% egg lethal dose (ELD50), 50% egg infectious dose (EID50), dwarf embryo, growth curve, and genetic stability, are measured, which are comparable to the parental virus H120. There are no clinical symptoms and tissue lesions in the trachea and kidney in the rH120-QX(S)-infected specific-pathogen-free (SPF) chickens, demonstrating that this recombinant virus does not confer pathogenicity. Furthermore, protection studies show that there is 100% homologous protection of rH120-QX(S) to the virulent QX strain, as shown by the absence of clinical signs and no lethality. Taken together, our results demonstrate that swapping the S gene onto the H120 genetic backbone is a precise and effective way to produce genetically defined IBV vaccine candidates.https://www.frontiersin.org/articles/10.3389/fmicb.2022.883642/fullinfectious bronchitis virusvaccine H120QXS genereverse geneticsrH120-QX(S)
spellingShingle Wenlian Weng
Qingyan Liu
Qingyan Liu
Wenxiang Xue
Huan Wang
Shouguo Fang
Yingjie Sun
Lei Tan
Cuiping Song
Xusheng Qiu
Weiwei Liu
Chan Ding
Chan Ding
Ying Liao
Characterization of the Protective Efficacy Against QX Strain of a Recombinant Infectious Bronchitis Virus With H120 Backbone and QX Spike Gene
Frontiers in Microbiology
infectious bronchitis virus
vaccine H120
QX
S gene
reverse genetics
rH120-QX(S)
title Characterization of the Protective Efficacy Against QX Strain of a Recombinant Infectious Bronchitis Virus With H120 Backbone and QX Spike Gene
title_full Characterization of the Protective Efficacy Against QX Strain of a Recombinant Infectious Bronchitis Virus With H120 Backbone and QX Spike Gene
title_fullStr Characterization of the Protective Efficacy Against QX Strain of a Recombinant Infectious Bronchitis Virus With H120 Backbone and QX Spike Gene
title_full_unstemmed Characterization of the Protective Efficacy Against QX Strain of a Recombinant Infectious Bronchitis Virus With H120 Backbone and QX Spike Gene
title_short Characterization of the Protective Efficacy Against QX Strain of a Recombinant Infectious Bronchitis Virus With H120 Backbone and QX Spike Gene
title_sort characterization of the protective efficacy against qx strain of a recombinant infectious bronchitis virus with h120 backbone and qx spike gene
topic infectious bronchitis virus
vaccine H120
QX
S gene
reverse genetics
rH120-QX(S)
url https://www.frontiersin.org/articles/10.3389/fmicb.2022.883642/full
work_keys_str_mv AT wenlianweng characterizationoftheprotectiveefficacyagainstqxstrainofarecombinantinfectiousbronchitisviruswithh120backboneandqxspikegene
AT qingyanliu characterizationoftheprotectiveefficacyagainstqxstrainofarecombinantinfectiousbronchitisviruswithh120backboneandqxspikegene
AT qingyanliu characterizationoftheprotectiveefficacyagainstqxstrainofarecombinantinfectiousbronchitisviruswithh120backboneandqxspikegene
AT wenxiangxue characterizationoftheprotectiveefficacyagainstqxstrainofarecombinantinfectiousbronchitisviruswithh120backboneandqxspikegene
AT huanwang characterizationoftheprotectiveefficacyagainstqxstrainofarecombinantinfectiousbronchitisviruswithh120backboneandqxspikegene
AT shouguofang characterizationoftheprotectiveefficacyagainstqxstrainofarecombinantinfectiousbronchitisviruswithh120backboneandqxspikegene
AT yingjiesun characterizationoftheprotectiveefficacyagainstqxstrainofarecombinantinfectiousbronchitisviruswithh120backboneandqxspikegene
AT leitan characterizationoftheprotectiveefficacyagainstqxstrainofarecombinantinfectiousbronchitisviruswithh120backboneandqxspikegene
AT cuipingsong characterizationoftheprotectiveefficacyagainstqxstrainofarecombinantinfectiousbronchitisviruswithh120backboneandqxspikegene
AT xushengqiu characterizationoftheprotectiveefficacyagainstqxstrainofarecombinantinfectiousbronchitisviruswithh120backboneandqxspikegene
AT weiweiliu characterizationoftheprotectiveefficacyagainstqxstrainofarecombinantinfectiousbronchitisviruswithh120backboneandqxspikegene
AT chanding characterizationoftheprotectiveefficacyagainstqxstrainofarecombinantinfectiousbronchitisviruswithh120backboneandqxspikegene
AT chanding characterizationoftheprotectiveefficacyagainstqxstrainofarecombinantinfectiousbronchitisviruswithh120backboneandqxspikegene
AT yingliao characterizationoftheprotectiveefficacyagainstqxstrainofarecombinantinfectiousbronchitisviruswithh120backboneandqxspikegene